Wais Mohd, Nazish Iram, Samad Abdus, Beg Sarwer, Abusufyan S, Ajaj S Ajaz, Aqil Mohd
Maharashtra Educational Society, Humera Khan College of Pharmacy, Mumbai, India.
Recent Pat Antiinfect Drug Discov. 2012 Apr;7(1):53-9. doi: 10.2174/157489112799829701.
Diabetes mellitus is the most common endocrine disorder, affecting 16 million individuals in the United States and 200 million worldwide. Despite the use of advanced synthetic drugs for the treatment, use of herbal remedies is gaining higher importance because of synthetic drugs have drawbacks and limitations. The herbal drugs with antidiabetic activity are extensively formulated commercially because of easy availability, affordability and less side effects as compared to the synthetic antidiabetic drugs. Antidiabetic herbal formulations (AHF) are considered to be more effective for the management of diabetes. There are around 600 herbal drug manufacturers in India of which almost all manufacturers are developing AHF in addition to others. Till date, no article is published to give detailed information of the patents on AHF. Thus, this review article undertake the attempt for providing updated information on the type of diabetes and patented AHF which will enhance the existing knowledge of the researchers.
糖尿病是最常见的内分泌疾病，在美国有1600万人受其影响，全球范围内有2亿人患病。尽管使用先进的合成药物进行治疗，但由于合成药物存在缺点和局限性，草药疗法的重要性日益凸显。具有抗糖尿病活性的草药因其易于获取、价格实惠且与合成抗糖尿病药物相比副作用较小，而在商业上被广泛配制。抗糖尿病草药制剂（AHF）被认为对糖尿病的管理更有效。印度约有600家草药药品制造商，几乎所有制造商都在开发AHF以及其他产品。迄今为止，尚未发表文章详细介绍AHF的专利信息。因此，这篇综述文章试图提供有关糖尿病类型和专利AHF的最新信息，这将增进研究人员现有的知识。
